Results 41 to 50 of about 18,891 (220)

Blood Biomarkers of Helicobacter pylori‐Infected Chronic Gastritis in Active Versus Stable Phases: A Clinical Indicator Analysis Combined With Proteomic and Metabolomic Investigations

open access: yesiMetaMed, EarlyView.
Combining clinical data with serum proteomics and metabolomics, the HGB–CAPZB–acetic acid model was developed as a potential diagnostic index to distinguish the active and stable stages of Helicobacter pylori‐infected chronic gastritis, and the related mechanism was explored through multi‐omics.
Tiantong Jiang   +7 more
wiley   +1 more source

Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis

open access: yes, 2002
Background: beta-Defensins are a newly identified family of antimicrobial peptides that are expressed by epithelia on mucosal surfaces where their production is augmented by infection or inflammation.
Domizio, P.   +23 more
core   +1 more source

Chronic gastritis may predict risk of cerebral small vessel disease

open access: yesBMC Gastroenterology, 2023
Background and purpose Chronic gastritis, especially that caused by helicobacter pylori (HP) infection, has been associated with increased risk of ischemic stroke.
Cunsheng Wei   +6 more
doaj   +1 more source

Helicobacter pylori and atrophic gastritis

open access: yesBiomedicine & Pharmacotherapy, 1997
Infection with Helicobacter pylori plays a crucial role in the etiology of atrophic gastritis and gastric cancer. Studies suggest a nine-fold increased risk for both conditions in the presence of infection. The risk of atrophic gastritis in the presence of infection is dependent upon the severity of the gastritis.
E J, Kuipers, B J, Appelmelk
openaire   +2 more sources

Longitudinal Changes in the Serum Pepsinogen I/II Ratio With Progression of Gastric Atrophy

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Serum pepsinogen (PG) I/II ratio decreased with progression of gastric mucosal atrophy and showed consistent intra‐individual changes over time. In a large cohort with repeated endoscopic evaluations, longitudinal declines in the PG I/II ratio paralleled worsening atrophic stages.
Soie Chung   +5 more
wiley   +1 more source

Infection of Helicobacter pylori and Atrophic Gastritis Influence Lactobacillus in Gut Microbiota in a Japanese Population

open access: yesFrontiers in Immunology, 2018
BackgroundSuppression of gastric acid by proton pump inhibitors is associated with the increase of Lactobacillus in human gut microbiota. Gastric acid secretion is also suppressed by Helicobacter pylori infection and following atrophic gastritis. However,
Chikara Iino   +7 more
doaj   +1 more source

Xanthomas and precancerous changes of the stomach: an accidental combination or an important prognostic endoscopic marker?

open access: yesGastroenterologìa, 2023
Background. The article deals with the study of gastric xanthomas, benign accidental formations with an unknown etiopathogenesis, which, according to the literature, are associated with a number of pathological conditions (atrophic gastritis, intestinal ...
O.V. Simonova   +2 more
doaj   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Role of Narrow band Imaging (NBI) in Detection of H. Pylori induced gastric intestinal metaplasia in Egyptian patients [PDF]

open access: yesAl-Azhar International Medical Journal
Background: Helicobacter pylori (H. pylori) colonizes the stomach mucosa of over 50% of the global population. Persistent infection progresses from gastritis to atrophy, intestinal metaplasia, dysplasia, and gastric adenocarcinoma. In Egypt, H.
Ahmed Massoud   +3 more
doaj   +1 more source

Resolution of Levodopa/Dopa‐Decarboxylase Inhibitor—Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Microscopic colitis (MC) typically presents with chronic, non‐bloody watery diarrhea. Diagnosis requires endoscopy with colonic mucosal biopsies. The etiology is multifactorial, with several medications implicated, although only a few cases have been attributed to oral levodopa/dopa‐decarboxylase inhibitor (LDDCI) therapy.
Romana Hintner   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy